Movement Alert｜Boston Scientific Intraday Decline 3.3% in Regular Trading, market focus remains on guidance pressure despite Blackstone heart pump deal

Market Focus

Nov 06

On November 6, Boston Scientific fell 3.3% in Regular Trading, trading at $43.084 per share, with turnover of $20.4119 million.

The latest market-moving backdrop is that, despite Boston Scientific's previously announced $455 million collaboration with Blackstone Life Sciences to co-fund development of the VITALYST heart pump, investors remain more focused on near-term earnings and guidance pressure.

Background details show the company reported third-quarter adjusted EPS of $0.73, above the $0.72 consensus, and revenue of $5.14 billion, also ahead of expectations. However, it lowered full-year adjusted EPS guidance to $3.16 to $3.18 versus a $3.22 market estimate, and said fourth-quarter revenue is expected to fall 1% to 3%. The company had also said an earlier cybersecurity incident disrupted operations and weighed on sales and profit expectations.

(The above content is based on publicly available market information, generated by a program or algorithm, and is intended solely as a stock movement alert. It does not constitute investment advice or a basis for trading decisions.)

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

1
2
3
4
5
6
7
8
9
10

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://www.itiger.com/news/1153608766"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental"},"isCrawlerRequest":true,"__swrFallback__":{"@#url:\"https://stock-news.skytigris.cn/v3/news\",params:#id:\"1153608766\",edition:\"fundamental\",auth_exemption:1,,,undefined,":{"share":"https://ttm.financial/m/news/1153608766?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2026-11-06 22:36","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"1153608766","market":"us","top_or_hot":-1,"title":"Movement Alert｜Boston Scientific Intraday Decline 3.3% in Regular Trading, market focus remains on guidance pressure despite Blackstone heart pump deal","media":"Market Focus","content":"<p><p>On November 6, Boston Scientific fell 3.3% in Regular Trading, trading at $43.084 per share, with turnover of $20.4119 million.</p><p>The latest market-moving backdrop is that, despite Boston Scientific's previously announced $455 million collaboration with Blackstone Life Sciences to co-fund development of the VITALYST heart pump, investors remain more focused on near-term earnings and guidance pressure.</p><p>Background details show the company reported third-quarter adjusted EPS of $0.73, above the $0.72 consensus, and revenue of $5.14 billion, also ahead of expectations. However, it lowered full-year adjusted EPS guidance to $3.16 to $3.18 versus a $3.22 market estimate, and said fourth-quarter revenue is expected to fall 1% to 3%. The company had also said an earlier cybersecurity incident disrupted operations and weighed on sales and profit expectations.</p><p>(The above content is based on publicly available market information, generated by a program or algorithm, and is intended solely as a stock movement alert. It does not constitute investment advice or a basis for trading decisions.)</p></p>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Movement Alert｜Boston Scientific Intraday Decline 3.3% in Regular Trading, market focus remains on guidance pressure despite Blackstone heart pump deal</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nMovement Alert｜Boston Scientific Intraday Decline 3.3% in Regular Trading, market focus remains on guidance pressure despite Blackstone heart pump deal\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1054767329\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/51943b2858f75e05ca2ebb144b4e626a);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Market Focus </p>\n<p class=\"h-time\">2026-11-06 22:36</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p><p>On November 6, Boston Scientific fell 3.3% in Regular Trading, trading at $43.084 per share, with turnover of $20.4119 million.</p><p>The latest market-moving backdrop is that, despite Boston Scientific's previously announced $455 million collaboration with Blackstone Life Sciences to co-fund development of the VITALYST heart pump, investors remain more focused on near-term earnings and guidance pressure.</p><p>Background details show the company reported third-quarter adjusted EPS of $0.73, above the $0.72 consensus, and revenue of $5.14 billion, also ahead of expectations. However, it lowered full-year adjusted EPS guidance to $3.16 to $3.18 versus a $3.22 market estimate, and said fourth-quarter revenue is expected to fall 1% to 3%. The company had also said an earlier cybersecurity incident disrupted operations and weighed on sales and profit expectations.</p><p>(The above content is based on publicly available market information, generated by a program or algorithm, and is intended solely as a stock movement alert. It does not constitute investment advice or a basis for trading decisions.)</p></p>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"BSX","symbol_name":"波士顿科学","start_time":0,"source_url":"","article_id":"1153608766","we_media_id":"1054767329","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=1153608766","pubTimestamp":1793975784,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"Market Focus","introduction":"Track stock‘s movements and relevant news","home_visible":1,"id":"1054767329","head_image":"https://static.tigerbbs.com/51943b2858f75e05ca2ebb144b4e626a"},"summary":"On November 6, Boston Scientific fell 3.3% in Regular Trading, trading at $43.084 per share, with turnover of $20.4119 million.The latest market-moving backdrop is that, despite Boston Scientific's...","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"BSX":"波士顿科学"},"translate_title":"走势警报|波士顿科学常规交易盘中下跌 3.3%，尽管黑石心脏泵交易，市场焦点仍集中在指导压力上","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"BSX":1},"content_text":"On November 6, Boston Scientific fell 3.3% in Regular Trading, trading at $43.084 per share, with turnover of $20.4119 million.The latest market-moving backdrop is that, despite Boston Scientific's previously announced $455 million collaboration with Blackstone Life Sciences to co-fund development of the VITALYST heart pump, investors remain more focused on near-term earnings and guidance pressure.Background details show the company reported third-quarter adjusted EPS of $0.73, above the $0.72 consensus, and revenue of $5.14 billion, also ahead of expectations. However, it lowered full-year adjusted EPS guidance to $3.16 to $3.18 versus a $3.22 market estimate, and said fourth-quarter revenue is expected to fall 1% to 3%. The company had also said an earlier cybersecurity incident disrupted operations and weighed on sales and profit expectations.(The above content is based on publicly available market information, generated by a program or algorithm, and is intended solely as a stock movement alert. It does not constitute investment advice or a basis for trading decisions.)","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":true,"editions":null,"column":"","sentiment":"-1","news_tag":"","news_rank":0,"isVideo":false,"video":null,"symbols":[],"gpt_button":0,"need_auth":false,"need_login_tip":false,"code":"91000000","status":"200"}}}